Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer (HR+HER2-)

Explore clinical trials studying Breast Cancer (HR+HER2-). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer (HR+HER2-) trial results

Completed

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

NCT02791334

Conditions
Breast Cancer (HR+HER2-), Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • The START Center for Cancer Care San Antonio, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 14 locations
View Trial Details

Related conditions